Literature DB >> 11373314

Tartrate-resistant acid phosphatase (Acp 5): identification in diverse human tissues and dendritic cells.

A R Hayman1, P Macary, P J Lehner, T M Cox.   

Abstract

Histochemical demonstration of tartrate-resistant acid phosphatase (TRAP) is used for the specific identification of osteoclasts. The enzyme, which we have shown to be critical for normal bone development in mice, is also characteristic of monohistiocytes, including alveolar macrophages, and is associated with diverse pathological conditions such as Gaucher's disease and hairy cell leukemia. TRAP activity is enhanced in serum when bone resorption is increased, and the activity is used routinely to monitor treatment responses in Gaucher's disease. We have lately shown widespread expression of the enzyme in murine tissues with particular reference to the skin, thymus, gut epithelia, and isolated dendritic cells, suggesting a possible role in immunity. To further clarify the significance of TRAP in human physiology, we have examined its distribution in non-skeletal human tissues and in CD34+ -derived human dendritic cells. TRAP mRNA determined by Northern blotting analysis was expressed abundantly in spleen, liver, colon, lung, small intestine, kidney, stomach, testis, placenta, lymph node, thymus, peripheral blood leukocyte, bone marrow, and fetal liver. Expression of TRAP protein was investigated by immunohistochemistry, with which the enzyme was identified in multiple tissues. Histochemical staining detected enzymatically active protein in spleen, lung, skin, colon, stomach, and ileum. Active TRAP was identified in CD34+ -derived immature dendritic cells and co-localized to intracellular CD63 positive organelles. When these cells were matured by induction with LPS, the TRAP activity increased fivefold and remained within the cell during the phase associated with CD63 surface expression. Our findings demonstrate widespread expression of TRAP in human tissues. Its abundant expression in epithelia and dendritic cells suggests a potential role in antigen processing and in immune responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11373314     DOI: 10.1177/002215540104900601

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  18 in total

Review 1.  Extending the knowledge in histochemistry and cell biology.

Authors:  Wolfgang-Moritz Heupel; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2009-11-28       Impact factor: 4.304

2.  The C-terminal fragment of parathyroid hormone-related peptide promotes bone formation in diabetic mice with low-turnover osteopaenia.

Authors:  D Lozano; L Fernández-de-Castro; S Portal-Núñez; A López-Herradón; S Dapía; E Gómez-Barrena; P Esbrit
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

3.  Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.

Authors:  Serhan Zenger; Wentao He; Barbro Ek-Rylander; Daphne Vassiliou; Rickard Wedin; Henrik Bauer; Göran Andersson
Journal:  Clin Exp Metastasis       Date:  2010-10-22       Impact factor: 5.150

4.  Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity.

Authors:  Ekkehart Lausch; Andreas Janecke; Matthias Bros; Stefanie Trojandt; Yasemin Alanay; Corinne De Laet; Christian A Hübner; Peter Meinecke; Gen Nishimura; Mari Matsuo; Yoshiko Hirano; Sylvie Tenoutasse; Andrea Kiss; Rafael Fabiano Machado Rosa; Sharon L Unger; Raffaele Renella; Luisa Bonafé; Jürgen Spranger; Sheila Unger; Bernhard Zabel; Andrea Superti-Furga
Journal:  Nat Genet       Date:  2011-01-09       Impact factor: 38.330

5.  Hypothalamic Y2 receptors regulate bone formation.

Authors:  Paul A Baldock; Amanda Sainsbury; Michelle Couzens; Ronaldo F Enriquez; Gethin P Thomas; Edith M Gardiner; Herbert Herzog
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

6.  Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice.

Authors:  Amanda Sainsbury; Paul A Baldock; Christoph Schwarzer; Naohiko Ueno; Ronaldo F Enriquez; Michelle Couzens; Akio Inui; Herbert Herzog; Edith M Gardiner
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

7.  Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice.

Authors:  Rachel A Davey; Andrew G Turner; Julie F McManus; W S Maria Chiu; Francisca Tjahyono; Alison J Moore; Gerald J Atkins; Paul H Anderson; Cathy Ma; Vaida Glatt; Helen E MacLean; Cristina Vincent; Mary Bouxsein; Howard A Morris; David M Findlay; Jeffrey D Zajac
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

8.  Induction and cellular expression of tartrate resistant acid phosphatase during dextran sodium sulphate induced colitis in rats.

Authors:  Pernilla Lång; Stefan Lange; Dick Delbro; Göran Andersson
Journal:  Histochem Cell Biol       Date:  2009-10-11       Impact factor: 4.304

9.  Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly.

Authors:  Minjun Yu; Jose L Moreno; Joseph P Stains; Achsah D Keegan
Journal:  J Biol Chem       Date:  2009-09-28       Impact factor: 5.157

10.  Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures.

Authors:  Sofia Movérare-Skrtic; Petra Henning; Xianwen Liu; Kenichi Nagano; Hiroaki Saito; Anna E Börjesson; Klara Sjögren; Sara H Windahl; Helen Farman; Bert Kindlund; Cecilia Engdahl; Antti Koskela; Fu-Ping Zhang; Emma E Eriksson; Farasat Zaman; Ann Hammarstedt; Hanna Isaksson; Marta Bally; Ali Kassem; Catharina Lindholm; Olof Sandberg; Per Aspenberg; Lars Sävendahl; Jian Q Feng; Jan Tuckermann; Juha Tuukkanen; Matti Poutanen; Roland Baron; Ulf H Lerner; Francesca Gori; Claes Ohlsson
Journal:  Nat Med       Date:  2014-10-12       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.